CombiGene is a gene therapy company. It specializes in preclinical studies including biodistribution and toxicology studies, development of GMP-classified manufacturing methods, scaling up production volumes and strategic regulatory work. The company focuses on the treatment of focal epilepsy and lipodystrophy.